197 related articles for article (PubMed ID: 33843033)
1. Immunohistochemical Expression of Fatty Acid Synthase (FASN) is Correlated to Tumor Aggressiveness and Cellular Differentiation in Salivary Gland Carcinomas.
de Angelis CM; de Lima-Souza RA; Scarini JF; Egal ESA; do Amaral-Silva GK; de Oliveira Gondak R; de Almeida OP; Chone CT; Kowalski LP; Altemani A; Mariano FV
Head Neck Pathol; 2021 Dec; 15(4):1119-1126. PubMed ID: 33843033
[TBL] [Abstract][Full Text] [Related]
2. Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma-Specific Prognostic Relevance.
Siqueira JM; Mitani Y; Hoff CO; Bonini F; Guimaraes de Sousa L; Marques-Piubelli ML; Purushothaman A; Mitani M; Dai H; Lin SY; Spiotto MT; Hanna EY; McGrail DJ; El-Naggar AK; Ferrarotto R
Mod Pathol; 2024 Jan; 37(1):100371. PubMed ID: 38015043
[TBL] [Abstract][Full Text] [Related]
3. The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinoma.
Hirai H; Tada Y; Nakaguro M; Kawakita D; Sato Y; Shimura T; Tsukahara K; Kano S; Ozawa H; Okami K; Sato Y; Fushimi C; Shimizu A; Okamoto I; Takase S; Okada T; Sato H; Imanishi Y; Otsuka K; Watanabe Y; Sakai A; Ebisumoto K; Togashi T; Ueki Y; Ota H; Saigusa N; Takahashi H; Ando M; Urano M; Hanazawa T; Nagao T
Virchows Arch; 2020 Aug; 477(2):291-299. PubMed ID: 32103349
[TBL] [Abstract][Full Text] [Related]
4. Salivary gland-type cancers: cross-organ demographics of a rare cancer.
Tanzawa A; Saito K; Ota M; Takahashi K; Ohno I; Hanazawa T; Uzawa K; Takiguchi Y
Int J Clin Oncol; 2024 Jun; 29(6):755-763. PubMed ID: 38492066
[TBL] [Abstract][Full Text] [Related]
5. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of DOG-1 Expression in Salivary Gland Tumours and Comparison with Myoepithelial Markers.
Khurram SA; Speight PM
Head Neck Pathol; 2019 Jun; 13(2):140-148. PubMed ID: 29671211
[TBL] [Abstract][Full Text] [Related]
7. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
Prasad AR; Savera AT; Gown AM; Zarbo RJ
Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
[TBL] [Abstract][Full Text] [Related]
8. Ki-67 and p53 immunostaining assessment of proliferative activity in salivary tumors.
Faur AC; Sas I; Motoc AG; Cornianu M; Zamfir CL; Lazăr DC; Folescu R
Rom J Morphol Embryol; 2015; 56(4):1429-39. PubMed ID: 26743291
[TBL] [Abstract][Full Text] [Related]
9. Comparison of p63/p40 Expression With Myoepithelial Markers in Minor Salivary Gland Tumors.
Teixeira LN; Janner ÉC; Teixeira T; Passador-Santos F; Martinez EF; Demasi APD; de Araújo NS; de Araújo VC
Int J Surg Pathol; 2019 Jun; 27(4):360-371. PubMed ID: 30482064
[TBL] [Abstract][Full Text] [Related]
10. NR4A3 Immunohistochemistry Reliably Discriminates Acinic Cell Carcinoma from Mimics.
Wong KS; Mariño-Enriquez A; Hornick JL; Jo VY
Head Neck Pathol; 2021 Jun; 15(2):425-432. PubMed ID: 32910350
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid synthase and Ki-67 immunoexpression can be useful for the identification of malignant component in carcinoma ex-pleomorphic adenoma.
Díaz KP; Gondak R; Martins LL; de Almeida OP; León JE; Mariano FV; Altemani A; Vargas PA
J Oral Pathol Med; 2019 Mar; 48(3):232-238. PubMed ID: 30597641
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis value of TTF-1, Napsin A and Ki-67 index in primary salivary gland-type lung carcinomas].
Zhang B; Lin J; Da J
Zhonghua Bing Li Xue Za Zhi; 2015 Jul; 44(7):499-503. PubMed ID: 26705042
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of the expression of fatty acid synthase and Ki-67 in salivary gland tumors.
do Prado RF; da Silva Machado AL; Colombo CE; Carvalho YR
J Oral Pathol Med; 2011 Jul; 40(6):467-75. PubMed ID: 21385214
[TBL] [Abstract][Full Text] [Related]
14. GATA3 immunohistochemical expression in salivary gland neoplasms.
Schwartz LE; Begum S; Westra WH; Bishop JA
Head Neck Pathol; 2013 Dec; 7(4):311-5. PubMed ID: 23604756
[TBL] [Abstract][Full Text] [Related]
15. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
Patel KR; Solomon IH; El-Mofty SK; Lewis JS; Chernock RD
Hum Pathol; 2013 Nov; 44(11):2501-8. PubMed ID: 24029710
[TBL] [Abstract][Full Text] [Related]
16. High-grade Transformation/Dedifferentiation in Salivary Gland Carcinomas: Occurrence Across Subtypes and Clinical Significance.
Skalova A; Leivo I; Hellquist H; Agaimy A; Simpson RHW; Stenman G; Vander Poorten V; Bishop JA; Franchi A; Hernandez-Prera JC; Slouka D; Willems SM; Olsen KD; Ferlito A
Adv Anat Pathol; 2021 May; 28(3):107-118. PubMed ID: 33825717
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Detection of Proliferative Marker Ki-67 in Benign and Malignant Salivary Gland Tumors.
Bussari S; Ganvir SM; Sarode M; Jeergal PA; Deshmukh A; Srivastava H
J Contemp Dent Pract; 2018 Apr; 19(4):375-383. PubMed ID: 29728539
[No Abstract] [Full Text] [Related]
18. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas.
Abd Raboh NM; Hakim SA
Int J Clin Exp Pathol; 2015; 8(8):9214-22. PubMed ID: 26464669
[TBL] [Abstract][Full Text] [Related]
19. Epithelial membrane antigen and DOG1 expression in minor salivary gland tumours.
Andrade EP; Teixeira LN; Montalli VAM; Garcia FM; Passador-Santos F; Soares AB; Araújo VC
Ann Diagn Pathol; 2019 Dec; 43():151408. PubMed ID: 31629156
[TBL] [Abstract][Full Text] [Related]
20. The potential of somatostatin receptor 2 as a novel therapeutic target in salivary gland malignant tumors.
Meirovitz A; Shouchane-Blum K; Maly A; Bersudski E; Hirshoren N; Abrams R; Popovtzer A; Orevi M; Weinberger J
J Cancer Res Clin Oncol; 2021 May; 147(5):1335-1340. PubMed ID: 33598797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
